Sipai Health Technology (0314) Fundamentals 2026 — Revenue Analysis | SniperIQ

.32 on the HKSE. This SniperIQ fundamentals page covers Sipai Health Technology's valuation, profitability (net margin -5.9%), revenue (¥2.0B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.

Full research coverage

• 8-Quarter Revenue & Margin Trend
• Debt Maturity & Coverage
• Peer Valuation Comparison
• Free Cash Flow & Owner Earnings
• AI Signal + Institutional Flow
• DCF Valuation Model

Frequently Asked Questions

What is Sipai Health Technology's market cap?

Sipai Health Technology (0314) has a market capitalization of approximately HK$960M, trading at HK

.32 on the HKSE. Market cap moves with the live share price.

What is Sipai Health Technology's P/E ratio?

Sipai Health Technology's trailing twelve-month P/E ratio is not meaningful (negative or nil earnings), with a price-to-book (P/B) of 0.7x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.

How profitable is Sipai Health Technology?

Sipai Health Technology runs a net profit margin of -5.9%, a gross margin of 14.4%, and an operating margin of -5.1%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.

How much revenue does Sipai Health Technology generate?

Sipai Health Technology reported revenue of ¥2.0B for fiscal year 2025, with net income of -¥121M and earnings per share (EPS) of -0.2. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.

Does Sipai Health Technology pay a dividend?

Sipai Health Technology does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.

Is Sipai Health Technology financially healthy?

Sipai Health Technology carries a debt-to-equity ratio of 0.02x and a current ratio of 1.83x, with a market beta of -0.59. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.

Is Sipai Health Technology a good stock to buy in 2026?

SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Sipai Health Technology (0314) the key facts are: market cap HK$960M, revenue ¥2.0B, 52-week range 1.13-6.88. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.